Maculopathy? There’s New Hope: EyeMax!
Imagine being able to see clearly again. With EyeMax, it’s possible!
This revolutionary intraocular lens:
Projects sharp images onto the peripheral macula
Maximizes your remaining vision
EyeMax is designed for those, like you, who are battling central vision loss.
Don’t let maculopathy darken your world. Take the first step towards better vision!
What is EyeMax?
EyeMax Mono belongs to the family of intraocular lenses (IOLs), which are implanted directly into the eye through a micro-surgical procedure to permanently correct common eye conditions such as myopia, hyperopia, astigmatism, and cataracts.
Specifically, EyeMax Mono is an advanced and highly sophisticated evolution of the AMD IOL lens (also known as the “Hubble Implant”), the world’s first injectable and telescopic microscope lens designed for macular diseases.
How EyeMax Mono Works
Maculopathies affect the macula, that is, the part of the retina responsible for central vision, and cause a more or less significant loss of vision at the center of the visual field.
They are progressive and unfortunately irreversible diseases: the area of the macula affected by maculopathy cannot in fact heal.
However, through EyeMax Mono, it is possible to “exploit” the still intact areas of the retina, extending the usable portion of the macula by 10 degrees in every direction and thus improving patients’ vision.
Here is how it works: the EyeMax Mono lens is injected into the eye through a small incision, its advanced lens gently magnifies the image that enters the eye and projects it onto the intact areas of the retina that surround the damaged macula. The brain then uses the image that reaches the healthier parts of the eye to offer the patient better vision.
Read also: EyeMax Mono: The Innovative Intraocular Lens to Improve Vision in Patients with Dry AMD
The procedure is very short (about 10 minutes) and does not require an overnight stay.
The surgical risks are no greater than those of a normal cataract surgery, with the difference that the benefits provided by the Eyemax Mono lens are much more long-lasting than those of any other intraocular lens.
The implantation method is designed to maximize the protection of the eye’s integrity (the lens is positioned in such a way that the delicate sections of the front part of the eye are preserved), allowing for a rapid post-operative recovery.
Conceived by the ophthalmic surgeon Dr. Bobby Qureshi and the optical physicist Pablo Artal, Eyemax Mono can truly improve vision and revolutionize the lives of many people who today suffer from reduced vision due to macular diseases, including early, intermediate, and terminal stages of age-related macular degeneration (Dry AMD) and diabetic maculopathy.
Depending on the residual visual potential, Eyemax Mono can indeed restore lost vision, allowing patients to drive again, see faces and objects clearly, read. In one word, significantly increase the quality of life.
Who is Eyemax Mono suitable for
Eyemax Mono is, to date, the most significant innovation in the surgical treatment of macular diseases, and after years of research and development, it is now available in Italy.
It is necessary to carefully evaluate with your ophthalmic doctor if you are the most suitable patient for the procedure. In general, the lens can help people affected by dry maculopathy and stabilized forms of wet maculopathy, as well as other types of macular diseases such as diabetic maculopathies and hereditary retinal diseases.
People who have already undergone cataract surgery can also benefit from the procedure. The results obviously vary from person to person depending on the severity of the initial disease and the extent of the residual visual field, but they can be truly remarkable.
